April 22, 2021

PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer

PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer

Chabanon RM, Morel D, Eychenne T, Colmet-Daage L, Bajrami I, Dorvault N, Garrido M, Meisenberg C, Lamb A, Ngo C, Hopkins SR, Roumeliotis TI, Jouny S, Hénon C, Kawai-Kawachi A, Astier C, Konde A, Del Nery E, Massard C, Pettitt SJ, Margueron R, Choudhary JS, Almouzni G, Soria JC, Deutsch E, Downs JA, Lord CJ, Postel-Vinay S. PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer. Cancer Res. 2021 Apr 22. doi: 10.1158/0008-5472.CAN-21-0628. Epub ahead of print. PMID: 33888468.


SHARE